Using Stock Options to Motivate Improved Performance and Retain Talent
First written in FY2016. 5 of 14 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
- FY2026Change in the number of outstanding stock optionsAnnual report
「2022 stock acquisition rights Number of stock acquisition rights: 205 2024 stock acquisition rights Number of stock acquisition rights: 3,455 Number of underlying shares: 345,500 shares Exercise period for stock acquisition rights: from 22 June 2026 to 21 June 2029」
The outstanding balance of the 2024 stock acquisition rights changed from the previously reported 4,140 to 3,455, while the 2022 stock acquisition rights changed from 270 to 205. - FY2025Change in the number of outstanding stock optionsAnnual report
「2024 stock acquisition rights: 3,515 rights. Number of underlying shares: 351,500 shares. Exercise period for stock acquisition rights: from 22 June 2026 to 21 June 2029」
The number of shares underlying the 2024 stock options changed from the 425,500 reported previously to 351,500. The exercise period is from June 2026 to June 2029. - FY2025-H1AdvancedAnnual report
「Number of stock acquisition rights ※ 4,255 (Note) 1 Number of shares underlying stock acquisition rights ※ 425,500 shares (Note) 2 Exercise period for stock acquisition rights ※ From 22 June 2026 To 21 June 2029」
The company granted 2024 stock acquisition rights to 6 directors and 364 employees, covering 425,500 underlying shares, with an exercise period from June 2026 to June 2029. - FY2024-Q3Further decrease in the number of outstanding stock acquisition rightsAnnual report
「2022 stock acquisition rights (number of stock acquisition rights: 3,620). 2022 stock acquisition rights (number of stock acquisition rights: 240). The number decreased by 3,185 as a result of the waiver of rights by directors and employees.」
The stated balance of the 2022 stock acquisition rights decreased from 3,620 to 240 following the waiver of rights by directors and employees. - FY2024-Q2Significant decrease in the number of outstanding stock acquisition rightsAnnual report
「2022 stock acquisition rights (number of stock acquisition rights: 3,775). 2022 stock acquisition rights (number of stock acquisition rights: 270). The number decreased by 3,175 as a result of the waiver of rights by directors and employees.」
The company states that the outstanding balance of the 2022 stock acquisition rights fell significantly following the waiver of rights by directors and employees. - FY2024-Q1Waiver of stock acquisition rightsAnnual report
「Gain on reversal of stock acquisition rights - ※1 13,915」
The company recognized a gain on reversal of stock acquisition rights of ¥13,915 thousand following the waiver of rights by directors. The balance of rights relating to existing stock options has changed. - FY2023Change in unvested balanceAnnual report
「Before vesting (shares) Balance at end of previous consolidated fiscal year - Granted 406,500 Lapsed 56,500 Vested - Unvested balance 350,000」
After 406,500 shares of 2022 stock options were granted, 56,500 shares lapsed, leaving an unvested balance of 350,000 shares. - FY2022AdvancedAnnual report
「The type of shares underlying these stock acquisition rights is the company’s common shares, and the number of shares underlying each stock acquisition right (the “number of shares granted”) is 100. … Date of allotment of these stock acquisition rights: 1 September 2022」
After the exercise period for the old stock options ended, the company moved to issuing new stock acquisition rights for directors, outside directors and employees. The total was 4,065 rights, covering up to 406,500 shares, with an exercise period from 25 June 2024 to 24 June 2027. - FY2020AchievedAnnual report
「Exercise period: 1 October 2016 to 30 September 2019 Exercised (shares) 157,100 Lapsed (shares) 152,200 Unexercised balance (shares) —」
By the end of the exercise period for the 2016 stock options, 157,100 shares had been exercised and 152,200 shares had lapsed, leaving no unexercised balance. - FY2019RaisedAnnual report
「The underlying shares are the company’s common shares, with a maximum of 800,000 shares. … Exercise period for stock acquisition rights: 1 October 2019 to 30 September 2022」
In addition to the exercise and lapse of existing stock options during the fiscal year, the company resolved to establish a framework for issuing up to 800,000 shares under stock acquisition rights for directors, employees and others, exercisable from October 2019 to September 2022. - FY2018AdvancedAnnual report
「Exercised (shares) 35,700 Lapsed (shares) 17,000 Unexercised balance (shares) 483,300」
Of the stock options, 35,700 shares were exercised and 17,000 shares lapsed, leaving an unexercised balance of 483,300 shares. - FY2017AdvancedAnnual report
「2016 Stock Acquisition Rights (Stock Options) Number of shares 545,000 shares (Note) 1 Exercise period for stock acquisition rights 1 October 2016 to 30 September 2019」
The company granted stock options for 545,000 shares in 2016, and 60,300 shares, including those under the previous scheme, were exercised during the fiscal year. - FY2017-Q1AdvancedAnnual report
「Between 1 July 2016 and 31 July 2016, the total number of issued shares increased by 2,600 shares, capital increased by ¥1,677 thousand and capital surplus increased by ¥1,677 thousand as a result of the exercise of stock acquisition rights.」
During the period under review, 2,600 shares were issued through the exercise of existing stock acquisition rights. - FY2016First statedAnnual report
「We issue stock acquisition rights to directors, executive officers and employees of the company and its subsidiaries to motivate and encourage them to improve performance, secure talented personnel and contribute to enhancing the corporate value of the entire group.」
For the stock acquisition rights approved in June 2016, the number of shares was capped at 1,150,000, with an exercise period from 1 October 2016 to 30 September 2019.